乳房病変局在法市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

乳房病変局在法市場の世界市場規模は、2024年に13億2,200万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに27億9,100万米ドルに達し、2025年から2033年にかけて8.7％の成長率（CAGR）を示すと予測しています。

乳房病変局在法とは、疾患や傷害によって引き起こされる乳房組織の異常な変化（乳房病変とも呼ばれる）を検出するために採用されるさまざまな手技を指します。一般的に使用される方法には、ワイヤーの局在、カーボンマーキング、放射線誘導による潜在性病変の局在（ROLL）、放射性シードの局在（RSL）、磁気シードの局在（Magseed）、術中超音波（IOUS）などがあります。これらの技術は、医師や医療専門家が十分な情報を得た上で意思決定を行い、患者にとって理想的な治療や手術を決定するのに役立ちます。外科手術、画像診断、バイオメディカル技術の進歩に伴い、乳房病変局在法は著しく進化しており、現在医療分野における需要を牽引しています。

乳房病変局在法市場動向：

ライフスタイルの変化や不健康な食生活による乳がん患者の大幅な増加が、市場成長を牽引する主な要因です。これに加えて、乳腺腫瘤摘出術や外科的生検を必要とする患者数の増加が、標的病変の正確な除去を確実にする乳房病変局在法の需要を増大させています。さらに、乳がんの早期発見の利点に関する認識を広めるために、さまざまな国の行政機関が積極的な取り組みを行っています。例えば、オーストラリア政府は、2年ごとに50～74歳の女性にマンモグラフィを無料で提供する全国乳がん検診プログラム、BreastScreen Australiaを開始しました。これは、乳がん診断、生検、その他の関連医療処置に対する政府および民間の償還政策の増加、および主要企業による革新的な乳房病変局在デバイスの発売と相まって、市場成長の触媒となっています。さらに、研究開発（R&D）活動への重点的な投資が、市場プレーヤーに有利な機会を提供しています。また、バストアップのような美容整形手術を受ける人の増加、医療インフラの改善、技術の進歩、消費者の医療支出の増加などの他の要因も、市場の見通しを明るいものにしています。

本レポートで扱う主な質問

• 2024年の世界の乳房病変局在法市場の市場規模は？
• 2025-2033年の世界の乳房病変局在法市場の予想成長率は？
• 世界の乳房病変局在法市場を牽引する主要因は何か？
• 世界の乳房病変局在法市場に対するCOVID-19の影響は？
• 世界の乳房病変局在法市場のタイプ別内訳は？
• 世界の乳房病変局在法市場の用途別内訳は？
• 世界の乳房病変局在法市場のエンドユーザー別内訳は？
• 世界の乳房病変局在法市場の世界における主要地域は？
• 世界の乳房病変局在法市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の乳房病変局在法市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• ワイヤー
• 放射性同位元素
• 磁気トレーサー
• その他

第7章 市場内訳：用途別

• 腫瘍同定
• センチネルリンパ節同定
  • 主要セグメント
    • 乳房部分切除術
    • 乳房切除術

第8章 市場内訳：エンドユーザー別

• 病院
• 診断センター
• 腫瘍クリニック
• 外来手術センター

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Argon Medical Devices Inc.
  • Becton Dickinson and Company
  • Cook Group Incorporated
  • CP Medical Inc.（Theragenics Corporation）
  • Endomagnetics Ltd.
  • Hologic Inc.
  • IsoAid LLC
  • IZI Medical Products（Landauer Inc）
  • Laurane Medical LLC
  • Leica Biosystems Nussloch GmbH（Danaher Corporation）
  • Merit Medical Systems Inc.
  • Sterylab S.r.l

List of Figures

• Figure 1: Global: Breast Lesion Localization Methods Market: Major Drivers and Challenges
• Figure 2: Global: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Breast Lesion Localization Methods Market: Breakup by Type (in %), 2024
• Figure 5: Global: Breast Lesion Localization Methods Market: Breakup by Usage (in %), 2024
• Figure 6: Global: Breast Lesion Localization Methods Market: Breakup by End User (in %), 2024
• Figure 7: Global: Breast Lesion Localization Methods Market: Breakup by Region (in %), 2024
• Figure 8: Global: Breast Lesion Localization Methods (Wire Localization) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Breast Lesion Localization Methods (Wire Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Breast Lesion Localization Methods (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Breast Lesion Localization Methods (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Breast Lesion Localization Methods (Tumor Identification) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Breast Lesion Localization Methods (Tumor Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Breast Lesion Localization Methods (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Breast Lesion Localization Methods (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Breast Lesion Localization Methods (Oncology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Breast Lesion Localization Methods (Oncology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: North America: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: North America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: United States: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: United States: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Canada: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Canada: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Asia-Pacific: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Asia-Pacific: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: China: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: China: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Japan: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Japan: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: India: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: India: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: South Korea: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: South Korea: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Australia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Australia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Indonesia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Indonesia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Europe: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Europe: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Germany: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Germany: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: France: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: France: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: United Kingdom: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: United Kingdom: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Italy: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Italy: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Spain: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Spain: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Russia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Russia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Latin America: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Latin America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Brazil: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Brazil: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Mexico: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Mexico: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Middle East and Africa: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Middle East and Africa: Breast Lesion Localization Methods Market: Breakup by Country (in %), 2024
• Figure 76: Middle East and Africa: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Global: Breast Lesion Localization Methods Industry: SWOT Analysis
• Figure 78: Global: Breast Lesion Localization Methods Industry: Value Chain Analysis
• Figure 79: Global: Breast Lesion Localization Methods Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Breast Lesion Localization Methods Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Usage (in Million USD), 2025-2033
• Table 4: Global: Breast Lesion Localization Methods Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Breast Lesion Localization Methods Market: Competitive Structure
• Table 7: Global: Breast Lesion Localization Methods Market: Key Players

The global breast lesion localization methods market size reached USD 1,322 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,791 Million by 2033, exhibiting a growth rate (CAGR) of 8.7% during 2025-2033.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:

A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:

Breakup by Type:

• Wire Localization
• Radioisotope Localization
• Magnetic Tracers Localization
• Others

Breakup by Usage:

• Tumor Identification
• Sentinel Lymph Node Identification
• Lumpectomy
• Mastectomy

Breakup by End User:

• Hospitals
• Diagnostic Centres
• Oncology Clinics
• Ambulatory Surgical Centers

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report

• 1.What was the size of the global breast lesion localization methods market in 2024?
• 2.What is the expected growth rate of the global breast lesion localization methods market during 2025-2033?
• 3.What are the key factors driving the global breast lesion localization methods market?
• 4.What has been the impact of COVID-19 on the global breast lesion localization methods market?
• 5.What is the breakup of the global breast lesion localization methods market based on type?
• 6.What is the breakup of the global breast lesion localization methods market based on the usage?
• 7.What is the breakup of the global breast lesion localization methods market based on the end user?
• 8.What are the key regions in the global breast lesion localization methods market?
• 9.Who are the key players/companies in the global breast lesion localization methods market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Breast Lesion Localization Methods Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Wire Localization
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Radioisotope Localization
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Magnetic Tracers Localization
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Usage

• 7.1 Tumor Identification
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Sentinel Lymph Node Identification
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Lumpectomy
    • 7.2.2.2 Mastectomy
  • 7.2.3 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostic Centres
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Oncology Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Ambulatory Surgical Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Argon Medical Devices Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Cook Group Incorporated
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 CP Medical Inc. (Theragenics Corporation)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Endomagnetics Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Hologic Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 IsoAid LLC
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 IZI Medical Products (Landauer Inc)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Laurane Medical LLC
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Merit Medical Systems Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Sterylab S.r.l
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio